Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
1999-4-15
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0041-1345
pubmed:author
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1246-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:10083557-Acute Disease, pubmed-meshheading:10083557-Adult, pubmed-meshheading:10083557-Antibodies, Monoclonal, pubmed-meshheading:10083557-Antibodies, Monoclonal, Humanized, pubmed-meshheading:10083557-Cytomegalovirus Infections, pubmed-meshheading:10083557-Drug Administration Schedule, pubmed-meshheading:10083557-Europe, pubmed-meshheading:10083557-Graft Rejection, pubmed-meshheading:10083557-Humans, pubmed-meshheading:10083557-Immunoglobulin G, pubmed-meshheading:10083557-Immunosuppressive Agents, pubmed-meshheading:10083557-Infusions, Intravenous, pubmed-meshheading:10083557-Kidney Transplantation, pubmed-meshheading:10083557-Muromonab-CD3, pubmed-meshheading:10083557-Mycophenolic Acid, pubmed-meshheading:10083557-Postoperative Complications, pubmed-meshheading:10083557-Steroids, pubmed-meshheading:10083557-United States
pubmed:articleTitle
Can antibody prophylaxis allow sparing of other immunosuppressives?
pubmed:affiliation
University of California, San Francisco, Kidney Transplant Service 94143-0116, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study